Similar articles

• Case of linear porokeratosis: successful treatment with topical 5% imiquimod cream.

  Ahn SJ, Lee HJ, Chang SE, Lee MW, Choi JH, Moon KC, Koh JK. Ahn SJ, et al. J Dermatol. 2007 Feb;34(2):146-7. doi: 10.1111/j.1346-8138.2006.00236.x. J Dermatol. 2007. PMID: 17239156 No abstract available.
• A case of porokeratosis ptychotropica: successful treatment with topical 5% imiquimod cream.

  Kawakami Y, Mitsui S. Kawakami Y, et al. Clin Exp Dermatol. 2017 Oct;42(7):839-841. doi: 10.1111/ced.13117. Epub 2017 May 22. Clin Exp Dermatol. 2017. PMID: 28543397 No abstract available.
• Human papillomavirus isolated from transplant-associated porokeratoses of mibelli responsive to topical 5% imiquimod cream.

  Esser AC, Pittelkow MR, Randle HW. Esser AC, et al. Dermatol Surg. 2006 Jun;32(6):858-61. doi: 10.1111/j.1524-4725.2006.32176.x. Dermatol Surg. 2006. PMID: 16792657 No abstract available.
• A review of imiquimod 5% cream for the treatment of various dermatological conditions.

  Salasche S, Shumack S. Salasche S, et al. Clin Exp Dermatol. 2003 Nov;28 Suppl 1:1-3. doi: 10.1046/j.1365-2230.28.s1.1.x. Clin Exp Dermatol. 2003. PMID: 14616801 Review. No abstract available.
• Topical imiquimod.

  Pearson GW, Langley RG. Pearson GW, et al. J Dermatolog Treat. 2001 Mar;12(1):37-40. doi: 10.1080/095466301750163572. J Dermatolog Treat. 2001. PMID: 12171687 Review.